The results showed a high tumor mutational burden (TMB) of 87.9 mutations/megabase, microsatellite stability, POLE mutation, BRAF p.D594G mutation, and PIK3CA p.R88Q missense mutation. The gene discussed is POLE; the disease is neoplasm.